Drug Profile
Capsaicin transdermal - Samyang
Alternative Names: Capsaicin plaster - SamyangLatest Information Update: 28 Oct 2021
Price :
$50
*
At a glance
- Originator Samyang Biopharmaceuticals Corporation; Samyang Group
- Developer Samyang Biopharmaceuticals Corporation
- Class Analgesics; Antipruritics; Catechols; Local anaesthetics; Monounsaturated fatty acids; Non-opioid analgesics; Polyunsaturated alkamides; Small molecules
- Mechanism of Action Substance P inhibitors; TRPV1 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Discontinued Neuropathic pain
Most Recent Events
- 01 Oct 2014 No development reported - Phase-II for Neuropathic pain in South Korea (Transdermal)